We are live on ! Find out more
CG

Column Group Portfolio holdings

AUM $88.1M
1-Year Est. Return 148.03%
This Fund
S&P 500
This Quarter Est. Return
-23.01%
1 Year Est. Return
+148.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+23.89%
10 Year Est. Return
–
AUM
$151M
AUM Growth
-$107M
Cap. Flow
-$40.1M
Cap. Flow %
-26.65%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
2
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
RVMD icon
Revolution Medicines
RVMD
+$39.9M
2
EFTR
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
+$197K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RAPT
1
DELISTED
RAPT Therapeutics
RAPT
$44.6M 29.58%
335,078
– –
RVMD icon
2
Revolution Medicines
RVMD
$43.7B
$34.1M 22.62%
1,230,641
-1,346,579
-52% -$39.9M
TNYA icon
3
Tenaya Therapeutics
TNYA
$163M
$24M 15.92%
9,400,290
– –
ORIC icon
4
Oric Pharmaceuticals
ORIC
$1.44B
$21.6M 14.33%
3,568,181
– –
NGM
5
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$19.4M 12.89%
18,136,735
– –
SRZN icon
6
Surrozen
SRZN
$282M
$4.61M 3.06%
627,653
– –
EFTR
7
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$2.42M 1.6%
161,049
-11,324
-7% -$197K

Similar funds

PIS
POM Investment Strategies Raleigh, North Carolina $88.3M AUM 15.23% 1-Year Est. Return
FWM
FSR Wealth Management Elmhurst, Illinois $87.8M AUM 10.63% 1-Year Est. Return
WP
Walleye Partners Madison, Wisconsin $87.7M AUM
SHCM
Stone House Capital Management Bay Harbor Islands, Florida $88.5M AUM 149.16% 1-Year Est. Return
YIM
Yoffe Investment Management Lemoyne, Pennsylvania $87.4M AUM 30.8% 1-Year Est. Return
VPW
Variant Private Wealth Tysons, Virginia $88.9M AUM 25.07% 1-Year Est. Return
LC
Luminist Capital Grand Rapids, Michigan $89M AUM 17.66% 1-Year Est. Return
BI
Bradyco Inc Cambridge, Massachusetts $87.2M AUM 8.85% 1-Year Est. Return

Column Group's Q3 2023 Portfolio in Review

As of Q3 2023, Column Group held 7 positions worth $151M, down 42% from $258M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Column Group withdrew a net $40.1M in Q3 2023, reducing 2 holdings. Its largest reduction was Revolution Medicines, cutting an estimated $39.9M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Column Group's biggest Q3 2023 reduction was Revolution Medicines, cutting an estimated $39.9M.
  • Column Group's ten largest holdings make up 100% of its $151M portfolio in Q3 2023.
  • Column Group opened 0 new positions and closed 0 in Q3 2023.
  • Column Group's portfolio value fell 42% quarter-over-quarter to $151M.

Based on Column Group's 13F filing for Q3 2023, filed 13 Nov 2023.